FIELD: medicine.
SUBSTANCE: invention refers to a contrast composition in the form of an aqueous solution for magnetic-resonance and X-ray diagnostics containing gadolinium oxide (Cd2O3), diethylene triaminopentaacetic acid (DTPA), medical polymer - polyvinylpyrrolidone of molar mass (12000±5000) Da in amount 0.5-5 wt % and pH 5.0-8.5.
EFFECT: invention provides preparation of the composition with the lower content of free gadolinium ensured by DTPA/Cd2O3 concentrations related as 2,035-2,10 that exceeds the stoichiometric ratio.
2 cl, 3 dwg, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
MAGNETIC RESONANCE AND RADIOPAQUE COMPOSITION | 2006 |
|
RU2308290C1 |
MEGNETIC-RESONANCE OPAQUE COMPOSITION | 1998 |
|
RU2150961C1 |
PREPARATION FOR APPLICATION IN PHOTON CAPTURE THERAPY OF MALIGNANT SOLID NEOPLASMS | 2015 |
|
RU2611379C1 |
GADOPENTETATE-MODIFIED BETA-CYCLODEXTRIN DERIVATIVES | 2013 |
|
RU2541090C1 |
MEDICINAL CONTRAST COMPOSITION | 2016 |
|
RU2639390C2 |
CONTRAST COMPOSITION FOR MAGNETIC RESONANCE IMAGING AND ANGIOGRAPHY BASED ON Mn-DCTA | 2020 |
|
RU2776412C2 |
HEPATOTROPHIC MAGNETIC RESONANCE CONTRAST MEDIUM BASED ON GADOLINIUM CHELATE COMPLEX | 2016 |
|
RU2663469C2 |
METHOD OF MAKING CHROMATOGRAPHIC GENERATOR OF TECHNETIUM-99m FROM NEUTRON-IRRADIATED MOLYBDENUM-98 | 2008 |
|
RU2403640C2 |
COMPOSITIONS CONTAINING COMPLEXES OF METALS OF SERIES OF LANTHANIDES | 2015 |
|
RU2707070C2 |
METHOD FOR ASSESSING QUANTITATIVE ACCUMULATION OF A PARAMAGNETIC CONTRAST PREPARATION GDOF-Mn-DTPA FOR MAGNETIC RESONANCE IMAGING OF EXPERIMENTAL ANIMALS | 2018 |
|
RU2699334C1 |
Authors
Dates
2010-08-20—Published
2009-04-13—Filed